State Street Corp Agios Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 3,138,197 shares of AGIO stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,138,197
Previous 2,625,685
19.52%
Holding current value
$114 Million
Previous $58.5 Million
56.92%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$203 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$169 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$146 Million1.84% of portfolio
-
Armistice Capital, LLC New York, NY2.96MShares$108 Million1.18% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.99B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...